These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 26801674)
1. Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance. Zhan H; Jiang J; Luo C; Sun Q; Ke A; Sun C; Hu J; Hu Z; Hu B; Zhu K; Fan J; Zhou J; Huang X Tumour Biol; 2016 Jul; 37(7):9691-8. PubMed ID: 26801674 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition. Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis. Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
5. Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression. Yan Y; Huang P; Mao K; He C; Xu Q; Zhang M; Liu H; Zhou Z; Zhou Q; Zhou Q; Ou B; Liu Q; Lin J; Chen R; Wang J; Zhang J; Xiao Z Oncogene; 2021 Jan; 40(1):28-45. PubMed ID: 33051595 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA UC001kfo promotes hepatocellular carcinoma proliferation and metastasis by targeting α-SMA. Pan Y; Qin T; Yin S; Zhang X; Gao X; Mu L Biomed Pharmacother; 2017 Mar; 87():669-677. PubMed ID: 28088733 [TBL] [Abstract][Full Text] [Related]
7. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways. Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922 [TBL] [Abstract][Full Text] [Related]
8. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of Talin1 promotes hepatocellular carcinoma progression through activation of the ERK1/2 pathway. Chen P; Lei L; Wang J; Zou X; Zhang D; Deng L; Wu D Cancer Sci; 2017 Jun; 108(6):1157-1168. PubMed ID: 28375585 [TBL] [Abstract][Full Text] [Related]
10. C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial-mesenchymal transition. Hu WH; Hu Z; Shen X; Dong LY; Zhou WZ; Yu XX Exp Mol Pathol; 2016 Feb; 100(1):101-8. PubMed ID: 26475622 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-370 functions as a tumor suppressor in hepatocellular carcinoma via inhibition of the MAPK/JNK signaling pathway by targeting BEX2. Wang X; Zhu W; Xu C; Wang F; Zhu X; Sun Y; Guo Y; Fu X; Zhang Y; Zang Y J Hum Genet; 2019 Dec; 64(12):1203-1217. PubMed ID: 31530937 [TBL] [Abstract][Full Text] [Related]
12. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
13. Rce1 suppresses invasion and metastasis of hepatocellular carcinoma via epithelial-mesenchymal transition induced by the TGF-β1/H-Ras signaling pathway. Ma C; Yang Y; Xu L; Tu W; Chen F; Wang J J Cell Physiol; 2020 Mar; 235(3):2506-2520. PubMed ID: 31506952 [TBL] [Abstract][Full Text] [Related]
14. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related]
15. MXR7 facilitates liver cancer metastasis via epithelial-mesenchymal transition. Lv G; Tan Y; Lv H; Fang T; Wang C; Li T; Yu Y; Hu C; Wen W; Wang H; Yang W Sci China Life Sci; 2017 Nov; 60(11):1203-1213. PubMed ID: 28812296 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of SLC34A2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Invasion. Li Y; Chen X; Lu H Oncol Res; 2016 Oct; 24(6):511-519. PubMed ID: 28281971 [TBL] [Abstract][Full Text] [Related]
17. LRG1 suppresses the migration and invasion of hepatocellular carcinoma cells. Zhang Y; Luo Q; Wang N; Hu F; Jin H; Ge T; Wang C; Qin W Med Oncol; 2015 May; 32(5):146. PubMed ID: 25814288 [TBL] [Abstract][Full Text] [Related]
18. Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma. Asano T; Yamada S; Fuchs BC; Takami H; Hayashi M; Sugimoto H; Fujii T; Tanabe KK; Kodera Y Int J Oncol; 2017 May; 50(5):1647-1654. PubMed ID: 28350091 [TBL] [Abstract][Full Text] [Related]
19. BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma. Zhang P; Dong Z; Cai J; Zhang C; Shen Z; Ke A; Gao D; Fan J; Shi G Int J Immunopathol Pharmacol; 2015 Mar; 28(1):36-44. PubMed ID: 25816404 [TBL] [Abstract][Full Text] [Related]
20. Expression and inhibitory role of TIMP-3 in hepatocellular carcinoma. Shen B; Jiang Y; Chen YR; Zheng HC; Zeng W; Li YY; Yin A; Nie Y Oncol Rep; 2016 Jul; 36(1):494-502. PubMed ID: 27222429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]